1. Home
  2. ASRT vs FMY Comparison

ASRT vs FMY Comparison

Compare ASRT & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • FMY
  • Stock Information
  • Founded
  • ASRT 1995
  • FMY 2005
  • Country
  • ASRT United States
  • FMY United States
  • Employees
  • ASRT N/A
  • FMY N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • FMY Finance/Investors Services
  • Sector
  • ASRT Health Care
  • FMY Finance
  • Exchange
  • ASRT Nasdaq
  • FMY Nasdaq
  • Market Cap
  • ASRT 57.9M
  • FMY 50.6M
  • IPO Year
  • ASRT 1997
  • FMY N/A
  • Fundamental
  • Price
  • ASRT $0.66
  • FMY $12.04
  • Analyst Decision
  • ASRT Strong Buy
  • FMY
  • Analyst Count
  • ASRT 3
  • FMY 0
  • Target Price
  • ASRT $3.08
  • FMY N/A
  • AVG Volume (30 Days)
  • ASRT 284.6K
  • FMY 10.1K
  • Earning Date
  • ASRT 05-12-2025
  • FMY 01-01-0001
  • Dividend Yield
  • ASRT N/A
  • FMY 6.98%
  • EPS Growth
  • ASRT N/A
  • FMY N/A
  • EPS
  • ASRT N/A
  • FMY N/A
  • Revenue
  • ASRT $119,001,000.00
  • FMY N/A
  • Revenue This Year
  • ASRT N/A
  • FMY N/A
  • Revenue Next Year
  • ASRT $11.71
  • FMY N/A
  • P/E Ratio
  • ASRT N/A
  • FMY N/A
  • Revenue Growth
  • ASRT N/A
  • FMY N/A
  • 52 Week Low
  • ASRT $0.51
  • FMY $10.71
  • 52 Week High
  • ASRT $1.80
  • FMY $12.17
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 50.57
  • FMY 50.52
  • Support Level
  • ASRT $0.67
  • FMY $11.83
  • Resistance Level
  • ASRT $0.71
  • FMY $12.13
  • Average True Range (ATR)
  • ASRT 0.04
  • FMY 0.13
  • MACD
  • ASRT 0.00
  • FMY -0.00
  • Stochastic Oscillator
  • ASRT 52.69
  • FMY 55.41

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

Share on Social Networks: